Journal of Thyroid Disorders & Therapy
Open Access
ISSN: 2167-7948
+44 1300 500008
ISSN: 2167-7948
+44 1300 500008
Daniela Pop Gjorceva
Macedonia
Dr. Daniela Pop Gjorceva is a distinguished researcher and medical professional based at the Institute of Pathophysiology and Nuclear Medicine "Acad. Isak S. Tadzer" in Skopje, Macedonia. She has extensive training and experience in the fields of pathophysiology and nuclear medicine, specializing in the molecular mechanisms of diseases and the application of nuclear medicine techniques in clinical diagnostics and treatment. Dr. Pop Gjorceva's research interests focus on the role of nuclear medicine in diagnosing and treating various medical conditions, including cancers, cardiovascular diseases, and metabolic disorders. She is committed to advancing the understanding of disease mechanisms at the molecular level and developing innovative approaches to improve patient outcomes. Her work is characterized by a strong focus on translating scientific research into clinical practice. As part of her responsibilities, Dr. Pop Gjorceva collaborates with multidisciplinary teams to develop new diagnostic tools and treatment strategies that leverage the latest advancements in nuclear medicine. Dr. Pop Gjorceva is also an active educator, sharing her expertise with medical students and professionals. Her research has been widely recognized, and she continues to contribute significantly to the advancement of nuclear medicine and pathophysiology, both in Macedonia and internationally. Through her dedication to medical science, she strives to improve the diagnosis and treatment of complex diseases.
Case Report
Thyrotoxicosis Associated with Cholestatic Jaundice Treated with Therapeutic Plasma Exchange-Case Report
Author(s): Irfan Ahmeti, Viktorija Chalovska, Nevena Manevska, Pavlina Dzekova-Vidimliski, Vladimir Avramoski and Daniela Pop GjorcevaIrfan Ahmeti, Viktorija Chalovska, Nevena Manevska, Pavlina Dzekova-Vidimliski, Vladimir Avramoski and Daniela Pop Gjorceva
Thyroid disorders, especially thyrotoxicosis, are commonly associated with hepatic dysfunction, but cholestasis is rarely reported. Heart failure, infection, weight loss may play role in the pathogenesis of cholestasis. Cholestasis could be worsened by treatment of hyperthyroidism using Thiamazole, but cholestasis in undiagnosed thyrotoxicosis is uncommon. We present 23 year old female with jaundice, goiter, palpitation and confirmed thyrotoxicosis associated with hepatomegaly, hepatocelluar damage and cholestasis. Liver biopsy excluded the suspicion of autoimmune hepatitis. Therapeutic plasma exchange was performed 5 days after starting the treatment with thyroid supressive therapy, and hepatoprotective therapy due to progressive increase of serum levels of bilirubin (conjugated/direct) and liver enzymes. The patient treatment continued with low doses of thyroid suppressive the.. View More»
DOI:
10.4172/2167-7948.1000211